COLORECTAL CANCER (CRC)

Clinical trials for COLORECTAL CANCER (CRC) explained in plain language.

Never miss a new study

Get alerted when new COLORECTAL CANCER (CRC) trials appear

Sign up with your email to follow new studies for COLORECTAL CANCER (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 24 Not yet recruiting 6 Not yet finished but already full! 5 Completed 3 Terminated 1

First human test of new pill targets 'Undruggable' cancer mutation

Disease control Terminated

This early-stage study tested a new oral drug, AZD0022, alone and combined with another cancer drug, in people with advanced solid tumors driven by a specific genetic change called KRASG12D. The main goals were to find a safe dose and see if the treatment caused any side effects.…

Matched conditions: COLORECTAL CANCER (CRC)

Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

COLORECTAL CANCER (CRC)

Get alerted when new COLORECTAL CANCER (CRC) trials appear

First human test of new pill targets 'Undruggable' cancer mutation